ARCA Biopharma Stock Future Price Prediction

ABIO
 Stock
  

USD 2.07  0.04  1.90%   

ARCA Biopharma stock price prediction is an act of determining the future value of ARCA Biopharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of ARCA Biopharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of ARCA Biopharma and does not consider all of the tangible or intangible factors available from ARCA Biopharma's fundamental data. We analyze noise-free headlines and recent hype associated with ARCA Biopharma, which may create opportunities for some arbitrage if properly timed.
Please continue to ARCA Biopharma Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of ARCA Biopharma based on different types of headlines from major news networks to social media. The ARCA Biopharma stock price prediction module provides an analysis of price elasticity to changes in media outlook on ARCA Biopharma over a specific investment horizon.
Wall Street Target Price
7.0
Using ARCA Biopharma hype-based prediction, you can estimate the value of ARCA Biopharma from the perspective of ARCA Biopharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ARCA Biopharma using ARCA Biopharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards ARCA Biopharma using crowd psychology based on the activity and movement of ARCA Biopharma's stock price.

ARCA Biopharma Implied Volatility

    
  230.03  
ARCA Biopharma's implied volatility exposes the market's sentiment of ARCA Biopharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ARCA Biopharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ARCA Biopharma stock will not fluctuate a lot when ARCA Biopharma's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in ARCA Biopharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in ARCA Biopharma to buy its stock at a price that has no basis in reality. In that case, they are not buying ARCA Biopharma because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

ARCA Biopharma after-hype prediction price

    
  USD 2.08  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of ARCA Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of ARCA Biopharma in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
1.865.687.92
Details
1 Analysts
Consensus
LowTarget PriceHigh
16.5016.5016.50
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ARCA Biopharma. Your research has to be compared to or analyzed against ARCA Biopharma's peers to derive any actionable benefits. When done correctly, ARCA Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in ARCA Biopharma.

ARCA Biopharma After-Hype Price Prediction Density Analysis

As far as predicting the price of ARCA Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ARCA Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ARCA Biopharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

ARCA Biopharma Estimiated After-Hype Price Volatility

In the context of predicting ARCA Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ARCA Biopharma's historical news coverage. ARCA Biopharma's after-hype downside and upside margins for the prediction period are 0.10 and 4.32, respectively. We have considered ARCA Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 2.07
2.08
After-hype Price
4.32
Upside
ARCA Biopharma is somewhat reliable asset. Analysis and calculation of next after-hype price of ARCA Biopharma is based on 3 months time horizon.

ARCA Biopharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as ARCA Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ARCA Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ARCA Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.11  2.24  0.01   0.10  11 Events / Month2 Events / MonthIn about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.072.080.48 
4,480  

ARCA Biopharma Hype Timeline

ARCA Biopharma is presently traded for 2.07. The entity has historical hype elasticity of 0.01 and average elasticity to hype of competition of 0.1. ARCA Biopharma is forecasted to increase in value after the next headline with the price projected to jump to 2.08 or above. The average volatility of media hype impact on the company stock price is over 100%. The price upswing on the next news is forecasted to be 0.48% whereas the daily expected return is presently at -0.11%. The volatility of related hype on ARCA Biopharma is about 255.51% with expected price after next announcement by competition of 2.17. Net Loss for the year was (19.32 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next forecasted press release will be in about 11 days.
Please continue to ARCA Biopharma Basic Forecasting Models to cross-verify your projections.

ARCA Biopharma Related Hype Analysis

Having access to credible news sources related to ARCA Biopharma's direct competition is more important than ever and may enhance your ability to predict ARCA Biopharma's future price movements. Getting to know how ARCA Biopharma rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ARCA Biopharma may potentially react to the hype associated with one of its peers.

ARCA Biopharma Additional Predictive Modules

Most predictive techniques to examine ARCA Biopharma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ARCA Biopharma using various technical indicators. When you analyze ARCA Biopharma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About ARCA Biopharma Predictive Indicators

The successful prediction of ARCA Biopharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ARCA Biopharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ARCA Biopharma based on analysis of ARCA Biopharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ARCA Biopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ARCA Biopharma's related companies.

Story Coverage note for ARCA Biopharma

The number of cover stories for ARCA Biopharma depends on current market conditions and ARCA Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ARCA Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ARCA Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

ARCA Biopharma Short Properties

ARCA Biopharma's future price predictability will typically decrease when ARCA Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ARCA Biopharma often depends not only on the future outlook of the potential ARCA Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ARCA Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding13903871.00
Cash And Short Term Investments53359000.00
Please continue to ARCA Biopharma Basic Forecasting Models to cross-verify your projections. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for analysis

When running ARCA Biopharma price analysis, check to measure ARCA Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARCA Biopharma is operating at the current time. Most of ARCA Biopharma's value examination focuses on studying past and present price action to predict the probability of ARCA Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ARCA Biopharma's price. Additionally, you may evaluate how the addition of ARCA Biopharma to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Is ARCA Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ARCA Biopharma. If investors know ARCA Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ARCA Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
30.3 M
Return On Assets
(0.17) 
Return On Equity
(0.29) 
The market value of ARCA Biopharma is measured differently than its book value, which is the value of ARCA Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of ARCA Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ARCA Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARCA Biopharma's market value can be influenced by many factors that don't directly affect ARCA Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARCA Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine ARCA Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARCA Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.